These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25715884)

  • 1. Does ketamine have anti-suicidal properties? Current status and future directions.
    Price RB; Mathew SJ
    CNS Drugs; 2015 Mar; 29(3):181-8. PubMed ID: 25715884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions.
    Lengvenyte A; Olié E; Courtet P
    Curr Psychiatry Rep; 2019 Dec; 21(12):132. PubMed ID: 31797066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
    Price RB; Iosifescu DV; Murrough JW; Chang LC; Al Jurdi RK; Iqbal SZ; Soleimani L; Charney DS; Foulkes AL; Mathew SJ
    Depress Anxiety; 2014 Apr; 31(4):335-43. PubMed ID: 24668760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions.
    Ryan K; Hosanagar A
    Curr Psychiatry Rep; 2023 Aug; 25(8):337-344. PubMed ID: 37389787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine as a fast acting antidepressant: current knowledge and open questions.
    Salvadore G; Singh JB
    CNS Neurosci Ther; 2013 Jun; 19(6):428-36. PubMed ID: 23578128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidality in treatment resistant depression: perspective for ketamine use.
    Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Słupski J; Włodarczyk A; Górska N; Szarmach J; Szałach ŁP; Wiglusz MS; Krysta K; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):258-260. PubMed ID: 31488737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine as augmentation for the treatment of major depression and suicidal risk in advanced cancer: Case report.
    Rodríguez-Mayoral O; Pérez-Esparza R; Domínguez-Ocadio G; Allende-Pérez S
    Palliat Support Care; 2020 Feb; 18(1):110-112. PubMed ID: 31397251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches.
    Al Jurdi RK; Swann A; Mathew SJ
    Curr Psychiatry Rep; 2015 Oct; 17(10):81. PubMed ID: 26307033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Study of Ketamine Infusion after Suicide Attempt: New Frontiers in Treating Acute Suicidality in a Real-World Medical Setting.
    Shivanekar S; Gopalan P; Pizon A; Spotts C; Cruz N; Lightfoot M; Rohac R; Baumeister A; Griffo A; Panny B; Kucherer S; Israel A; Rengasamy M; Price R
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.
    Mallick F; McCullumsmith CB
    Curr Psychiatry Rep; 2016 Jun; 18(6):61. PubMed ID: 27194043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine for Depression, 2: Diagnostic and Contextual Indications.
    Andrade C
    J Clin Psychiatry; 2017 May; 78(5):e555-e558. PubMed ID: 28570803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality.
    Kotzalidis GD; Fiaschè F; Alcibiade A; Monti L; Di Segni F; Mazza M; Sani G
    Expert Opin Pharmacother; 2024 Mar; 25(4):435-446. PubMed ID: 38517222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial.
    Knyahnytska Y; Zomorrodi R; Kaster T; Voineskos D; Trevizol A; Blumberger D
    JMIR Res Protoc; 2023 Jan; 12():e41013. PubMed ID: 36573651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review.
    Siegel AN; Di Vincenzo JD; Brietzke E; Gill H; Rodrigues NB; Lui LMW; Teopiz KM; Ng J; Ho R; McIntyre RS; Rosenblat JD
    J Psychiatr Res; 2021 May; 137():426-436. PubMed ID: 33774537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapid anti-suicidal ideation effect of ketamine: A systematic review.
    Hochschild A; Grunebaum MF; Mann JJ
    Prev Med; 2021 Nov; 152(Pt 1):106524. PubMed ID: 34538369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
    McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
    Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ
    Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.